Independent prognostic variables in acute myeloid leukaemiaSMITH, Matthew L; HILLS, Robert K; GRIMWADE, David et al.Blood reviews. 2011, Vol 25, Num 1, pp 39-51, issn 0268-960X, 13 p.Article

Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid LeukemiaGRIMWADE, David; MROZEK, Krzysztof.Hematology/oncology clinics of North America. 2011, Vol 25, Num 6, issn 0889-8588, vii, 1135-1161 [28 p.]Article

Biology and management of relapsed acute myeloid leukaemiaCRADDOCK, Charles; TAURO, Sudhir; MOSS, Paul et al.British journal of haematology. 2005, Vol 129, Num 1, pp 18-34, issn 0007-1048, 17 p.Article

The significance of minimal residual disease in patients with t(15;17)GRIMWADE, David.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 137-158, issn 1521-6926Article

The clinical significance of cytogenetic abnormalities in acute myeloid leukaemiaGRIMWADE, David.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 3, pp 497-529, issn 1521-6926Article

Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot―Leyden crystalsTAYLOR, Gordon; IVEY, Adam; MILNER, Benedict et al.International journal of hematology. 2013, Vol 98, Num 3, pp 267-268, issn 0925-5710, 2 p.Article

Mutation of the RAD51C gene in a Fanconi anemia― like disorderVAZ, Fiona; HANENBERG, Helmut; FRATERNALI, Franca et al.Nature genetics. 2010, Vol 42, Num 5, pp 406-409, issn 1061-4036, 4 p.Article

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosisKHIZER HASAN, Syed; MAYS, Ashley N; STEPHEN, Christopher et al.Blood. 2008, Vol 112, Num 8, pp 3383-3390, issn 0006-4971, 8 p.Article

Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia : impact on WHO classification. CommentaryGRIMWADE, David; PASQUALUCCI, Laura; MANNUCCI, Roberta et al.Blood. 2006, Vol 108, Num 13, issn 0006-4971, 3965,4146-4155 [11 p.]Article

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemiaFORONI, Letizia; WILSON, Gill; CLENCH, Tim et al.British journal of haematology. 2011, Vol 153, Num 2, pp 179-190, issn 0007-1048, 12 p.Article

Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia : implications for the cellular target of t(15;17). CommentaryMERCHER, Thomas; GILLILAND, D. Gary; GRIMWADE, David et al.Blood. 2006, Vol 108, Num 10, issn 0006-4971, 3234,3484-3493 [11 p.]Article

Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptorALTUCCI, Lucia; ROSSIN, Aurélie; ZELENT, Arthur et al.Cancer research (Baltimore). 2005, Vol 65, Num 19, pp 8754-8765, issn 0008-5472, 12 p.Article

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaGALE, Rosemary E; HILLS, Robert; BURNETT, Alan K et al.Blood. 2005, Vol 106, Num 12, pp 3768-3776, issn 0006-4971, 9 p.Article

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML) : analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialGRIMWADE, David; WALKER, Helen; HARRISON, Georgina et al.Blood. 2001, Vol 98, Num 5, pp 1312-1320, issn 0006-4971Article

Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responsesUTTENTHAL, Benjamin; MARTINEZ-DAVILA, Irma; MORRIS, Emma C et al.British journal of haematology. 2014, Vol 164, Num 3, pp 366-375, issn 0007-1048, 10 p.Article

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutationsBENCH, Anthony J; WHITE, Helen E; CLENCH, Tim et al.British journal of haematology. 2013, Vol 160, Num 1, pp 25-34, issn 0007-1048, 10 p.Article

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemiaMAYS, Ashley N; OSHEROFF, Neil; HOYLE, Christine et al.Blood. 2010, Vol 115, Num 2, pp 326-330, issn 0006-4971, 5 p.Article

Management of acute promyelocytic leukemia : recommendations from an expert panel on behalf of the European LeukemiaNetSANZ, Miguel A; GRIMWADE, David; BURNETT, Alan K et al.Blood. 2009, Vol 113, Num 9, pp 1875-1891, issn 0006-4971, 17 p.Article

Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet StudyCILLONI, Daniela; RENNEVILLE, Aline; IZZO, Barbara et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5195-5201, issn 0732-183X, 7 p.Article

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors : review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing resultsHUGHES, Timothy; DEININGER, Michael; GABERT, Jean et al.Blood. 2006, Vol 108, Num 1, pp 28-37, issn 0006-4971, 10 p.Article

Variability in the levels of PML-RARα fusion transcripts detected by laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocolsBOLUFER, Pascual; LO COCO, Francesco; MARUGAN, Isabel et al.Haematologica (Roma). 2001, Vol 86, Num 6, pp 570-576, issn 0390-6078Article

Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid LeukemiaFREEMAN, Sylvie D; VIRGO, Paul; COUZENS, Steve et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4123-4131, issn 0732-183X, 9 p.Article

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsGRIMWADE, David; HILLS, Robert K; MOORMAN, Anthony V et al.Blood. 2010, Vol 116, Num 3, pp 354-365, issn 0006-4971, 12 p.Article

Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemiasOMMEN, Hans Beier; SCHNITTGER, Susanne; JOVANOVIC, Jelena V et al.Blood. 2010, Vol 115, Num 2, pp 198-205, issn 0006-4971, 8 p.Article

Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide TherapyGRIMWADE, David; JOVANOVIC, Jelena V; RENNIE, Kristian et al.Journal of clinical oncology. 2009, Vol 27, Num 22, pp 3650-3658, issn 0732-183X, 9 p.Article